Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis.
Melissa McLeodPeter SandifordGiorgi KvizhinadzeKaren BartholomewSue CrenglePublished in: BMJ open (2020)
A national biennial LDCT lung cancer screening programme in New Zealand is likely to be cost-effective, will improve total population health and reduce health inequities for Māori. Attention must be paid to addressing ethnic inequities in stage-specific lung cancer survival.